Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating NLM-001 in combination with standard chemotherapy and Zalifrelimab for advanced pancreatic ductal adenocarcinoma. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• NLM-001
• Zalifrelimab (zalifrelimab)

Snippet

Sponsor: Nelum Corp | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING